[HTML][HTML] Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen

C Ayoub Moubareck, D Hammoudi Halat - Antibiotics, 2020 - mdpi.com
Being a multidrug-resistant and an invasive pathogen, Acinetobacter baumannii is one of
the major causes of nosocomial infections in the current healthcare system. It has been …

Considerations and caveats in combating ESKAPE pathogens against nosocomial infections

YX Ma, CY Wang, YY Li, J Li, QQ Wan… - Advanced …, 2020 - Wiley Online Library
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

[HTML][HTML] Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace

MS Ramirez, RA Bonomo, ME Tolmasky - Biomolecules, 2020 - mdpi.com
Acinetobacter baumannii is a common cause of serious nosocomial infections. Although
community-acquired infections are observed, the vast majority occur in people with …

Antibacterial Effects of Green‐Synthesized Silver Nanoparticles Using Ferula asafoetida against Acinetobacter baumannii Isolated from the Hospital Environment …

SN Abootalebi, SM Mousavi, SA Hashemi… - Journal of …, 2021 - Wiley Online Library
Acinetobacter baumannii (A. baumannii) is a dangerous nosocomial pathogen in intensive
care units, causing fatal clinical challenges and mortality. In this study, the green synthesis of …

[HTML][HTML] Virulence Potential and Treatment Options of Multidrug-Resistant (MDR) Acinetobacter baumannii

S Kumar, R Anwer, A Azzi - Microorganisms, 2021 - mdpi.com
Acinetobacter baumannii is an opportunistic pathogen which is undoubtedly known for a
high rate of morbidity and mortality in hospital-acquired infections. A. baumannii causes life …

[HTML][HTML] Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?

WG Lima, JCM Brito, WS da Cruz Nizer - Medical hypotheses, 2020 - ncbi.nlm.nih.gov
In late 2019, a cluster of pneumonia cases reported from Wuhan City (Hubei Province,
China) were associated with a novel betacoronavirus, first called the 2019 novel coronavirus …

[HTML][HTML] Ventilator-associated pneumonia in COVID-19 patients: a retrospective cohort study

M Rouyer, A Strazzulla, T Youbong, P Tarteret, A Pitsch… - Antibiotics, 2021 - mdpi.com
Introduction: Aim of this study is to analyse the characteristics of ventilator-associated
pneumonia (VAP) inpatients infected by severe acute respiratory syndrome-coronavirus 2 …

An overview of guidelines for the management of hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria

C Cillóniz, C Dominedo, A Torres - Current Opinion in Infectious …, 2019 - journals.lww.com
Due to the increasing prevalence of HAP/VAP caused by MDR Gram-negative pathogens,
management should be guided by the local ecology and the patient's risk factors for MDR …

[HTML][HTML] Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review

R Singh, N Capalash, P Sharma - 3 Biotech, 2022 - Springer
Acinetobacter baumannii has emerged as one of major nosocomial pathogen and global
emergence of multidrug-resistant strains has become a challenge for developing effective …